Princess Margaret Hospital
The researchers also surveyed treating oncologists about why they decided to change, or not change, the treatment approach.
Researchers Highlight Progress in Head and Neck Cancer MRD at ASCO, but Results Remain Preliminary
Premium
Clinicians said that residual disease tests could be of great benefit to this population, but advancing technologies will still have to prove themselves.
Multimodal Cell-Free DNA Test May Help Detect Cancer Early in Li-Fraumeni Syndrome Patients
Researchers analyzed cfDNA from blood focusing on genomic, fragmentomic, and epigenomic features linked to cancer in individuals with germline TP53 mutations.
Lung Cancer Study Suggests Liquid Biopsy Reduces Treatment Delays, Boosts Target Detection
A clinical trial suggests circulating tumor DNA genotyping prior to tissue-based diagnoses can reduce time to treatment in advanced NSCLC patients.
Personalized Residual Disease Assays Show Promise to Overcome Liquid Biopsy Challenges in Sarcomas
Premium
New data presented at the ASCO annual meeting this week showed that tumor-informed assays could detect emerging recurrence ahead of imaging.
Dec 5, 2022
Oct 6, 2021
Nov 21, 2018
Oct 5, 2017